Drug Shortage Report for JAMP-ALENDRONATE

Last updated on 2018-05-19 History
Report ID 42408
Drug Identification Number 02385031
Brand name JAMP-ALENDRONATE
Common or Proper name Alendronate
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 70MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-03-08
Estimated end date
Actual end date 2018-05-18
Shortage status Resolved
Updated date 2018-05-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-05-19 English Compare
v10 2018-05-18 French Compare
v9 2018-05-18 English Compare
v8 2018-05-01 French Compare
v7 2018-05-01 English Compare
v6 2018-04-27 French Compare
v5 2018-04-27 English Compare
v4 2018-03-09 French Compare
v3 2018-03-09 English Compare
v2 2018-03-09 French Compare
v1 2018-03-09 English Compare

Showing 1 to 11 of 11